Depressive symptoms are associated with use of opioids for non-pain symptoms, according to researchers
Get the latest industry news, event updates, and more from Managed healthcare Executive.
FDA Approves First Intranasal Diuretic, Enbumyst
Read More
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
Listen
Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns
Big Beautiful Bill Reduces Drugs Eligible for Price Negotiations
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain
Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s